Khir Eddine Osmani

• Deliver Best-in Class Launches across prioritized markets (US, UK, EU, GG, Brazil and China)
• Assist EU countries with pre-launch and launch preparation activities,
• Lead medical support to market access and regulatory team for EMA submission.
• Lead HSCT global medical activities. in close collaboration with global and local medical affairs adopting a local approach.
• Partnering with cross-functional teams (Commercial, MA, RA and CA) to ensure proactive and impactful medical support.
• Timely answer to countries requests and full medical support in local submission dossier building
• Leading preparation and execution of medical and evidence generation plans and contributing to franchise growth strategy building
• Oversee execution of countries' medical plans while delivering ongoing support.
• Spearhead Scientific Therapeutic Area leadership throughout organisation.
• Building advocacy and developing new partners by implementing and executing a strong stakeholders engagement plan.
• Elevate value proposition through clinical data generation and real-world evidence to distinguish from existing and emerging therapies.
• Ensure clear data dissemination strategy and robust sharing of science as per defined medical communications priorities
• Cultivate and Strengthen Leadership in TA, while redefining standards of care in adjacent fields through organic and inorganic innovations that will transform lives of patients.

• Develop and implement a comprehensive and tailored scientific engagement plan that support the strategic imperatives of the TA in both HSCT and SOT.
• Implement continuous review of strategies and activities across year, modifying approaches according to emerging data, competitive dynamics, and alterations in transplant field environment.
• Design cohesive approach for integrating scientific expert engagement, advancing medical education, and facilitating multichannel interactions.
• Facilitated collaboration between Global Medical Teams, Medical Leads, key markets, customer engagement team and commercial team to ensure seamless execution of scientific engagement strategy and plans.
• Cultivated external partnerships with KOLs and scientific societies to enhance collaboration.
  Established relationships with patient associations and advocacy groups for effective engagement.
  Collaborated with medical communication firms to develop strategic initiatives.
• Oversaw planning and organisation of scientific congresses and events.
  Managed compliance and transparency requirements for donations and contributions.
  Coordinated advisory board activities to ensure strategic alignment.

• Develop integrated strategies for scientific expert engagement and medical education.
• Collaborate with internal partnerships, including GMT/Medical Leads and customer engagement teams.
• Engage external partners such as KOLs and scientific societies to enhance outreach.
• Oversaw management of scientific congresses, ensuring compliance and transparency.
• Coordinate planning and organisation of advisory boards for strategic insights.
• Execute multichannel engagement strategies across key priority markets effectively.
• Facilitate seamless execution of scientific engagement strategies through cross-functional teamwork.

• Lead establishment of launch readiness medical plan for Sotagliflozin and contributed medical and clinical knowledge for shaping OAD portfolio strategy in emerging market territories.
• Lead the GLP-1 Launch Readiness Medical Plan for Russia, Algeria, KSA, GULF, Malaysia & Philippines and ensure the Implementation of the 2020 data generation Plan.

• Build Launch strategy for DCV new Products: Toujeo®, Soliqua®, Zemiglo® and Praluent® (Dyslipidemia)
• Manage a medical advisory service for DCV Algeria and create/consolidate a high performing Medical Office based and MSL team
• Ensure and improve Data Generation & Dissemination by preparing a solid clinical and publication planning

• Oversee medical advisory service to align with business opportunities and strategic medical objectives, addressing short-, medium-, and long-term business needs.
• Medical support to clinical operation team (Site selection, protocol review and validation, site training, Medical consistency, etc.).
• Medical support to Regulatory and Market Access on CVDs of new products.

• Prepare and implement Medical Awareness Program for GLP-1 therapy and Victoza® Pre-launch activities and Data dissemination.
• Collaborate with sales managers to address regional business requirements.
  Ensured alignment of RMAs with medical and marketing strategies.
• Identify and Develop new KOLs for National advisory boards (product-specific) as well as new potential site and investigator for CDP trials.
• Facilitate communication among diverse teams: Regional Medical Advisors, Medical Advisors, CRAs, Marketing Product Managers, Sales Managers, and Public Affairs.

• Ensure field medical strategies execution by building and maintaining relationships with healthcare professionals to communicate complex medical information, support clinical research, and provide insights to guide a company’s medical strategy.

Insulin portfolio medical sales representative

GP: Emergency Intensive Care dept